Combining the weight loss-inducing drugs with those that aim to build muscle mass has quickly become a priority for companies like Regeneron Pharmaceuticals and Eli Lilly, Bloomberg reported Jan. 10.
“There will be the drugs that get there first, and there will be the drugs that actually are the best. If you can address things such as tolerability or the muscle loss…you’ll see there will be room for drugs that actually do it better than the first generation,” Teresa Graham, CEO of Roche Pharmaceuticals, a company also working on a solution, told the Journal.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
